Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.
Clinical trial NCT00239109 · COMPLETED
Trial details
- NCT number
- NCT00239109
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.